Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Aug 6, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure
TL;DR
Dr. Reddy's Labs filed a 6-K, confirming 20-F filings and providing Hyderabad HQ details.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 6, 2024, to report information as a foreign private issuer. The filing confirms their submission of annual reports under Form 20-F and provides contact information for their principal executive office in Hyderabad, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing an update on their reporting status and corporate information to the SEC and investors.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate elevated risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-000869 (accession_number) — Filing identifier
- 20240806 (date) — Filing date
- Hyderabad, India (location) — Principal executive office location
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information to the SEC.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
The filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
Where is the principal executive office of Dr. Reddy's Laboratories Ltd. located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
What is the SIC code for Dr. Reddy's Laboratories Ltd.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-06 06:13:14
Filing Documents
- drr0655_6k.htm (6-K) — 13KB
- drr0655_ex99-1.htm (EX-99.1) — 7KB
- drr0655_ex99-1img01.jpg (GRAPHIC) — 8KB
- drr0655_ex99-1img02.jpg (GRAPHIC) — 6KB
- 0001575872-24-000869.txt ( ) — 41KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 5, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3